Frontiers in Oncology | Molecular and Cellular Oncology

Original Research

Published on 13 Oct 2023

Targeting of tumor cells by custom antigen transfer: a novel approach for immunotherapy of cancer

in Molecular and Cellular Oncology

Ilaria Nesi
Chiara Della Bella
Maria Letizia Taddei
Alice Santi
Erica Pranzini
Paolo Paoli
Mario Milco D’Elios
Matteo Ramazzotti
Massimo Genovese
Anna Caselli

Frontiers in Oncology

doi 10.3389/fonc.2023.1245248

2,153 views

Original Research

Published on 12 Oct 2023

Molecular landscape and clinical significance of exon 11 mutations in KIT gene among patients with gastrointestinal stromal tumor: a retrospective exploratory study

in Molecular and Cellular Oncology

Ruihua Zhao
Tianqi An
Min Liu
Yanan Zhou
Rui Li
Guozhong Jiang
Jing Li
Xinguang Cao
Hong Zong

Frontiers in Oncology

doi 10.3389/fonc.2023.1272046

3,912 views
1 citation

Review

Published on 12 Oct 2023

The relationship between cancer and biomechanics

in Molecular and Cellular Oncology

Liqi Bao
Hongru Kong
Yang Ja
Chengchao Wang
Lei Qin
Hongwei Sun
Shengjie Dai

Frontiers in Oncology

doi 10.3389/fonc.2023.1273154

6,899 views
21 citations

Review

Published on 11 Oct 2023

Tumor microenvironment-induced tumor cell plasticity: relationship with hypoxic stress and impact on tumor resistance

in Molecular and Cellular Oncology

RF. Zaarour
M. Ribeiro
B. Azzarone
S. Kapoor
S. Chouaib

Frontiers in Oncology

doi 10.3389/fonc.2023.1222575

4,756 views
11 citations

Retraction

Published on 10 Oct 2023

Retraction: MicroRNA-326 functions as a tumor suppressor in breast cancer by targeting ErbB/PI3K signaling pathway

in Molecular and Cellular Oncology

Frontiers Editorial Office

Frontiers in Oncology

doi 10.3389/fonc.2023.1298871

1,752 views
1 citation

Case Report

Published on 09 Oct 2023

NTRK rearranged sarcoma of the bone. Role for larotrectinib in the neoadjuvant setting of an ultra-rare tumor: a case report

in Molecular and Cellular Oncology

Emanuela Palmerini
Giorgio Frega
Marco Gambarotti
Tommaso Frisoni
Marilena Cesari
Alberto Bazzocchi
Marco Miceli
Davide Maria Donati
Stefano Fanti
Cristina Nanni

Frontiers in Oncology

doi 10.3389/fonc.2023.1252359

3,226 views
4 citations

Editorial

Published on 09 Oct 2023

Editorial: Tumour microenvironment heterogeneity in hematological malignancies

in Molecular and Cellular Oncology

Silvia Deaglio
Ingo Ringshausen

Frontiers in Oncology

doi 10.3389/fonc.2023.1295996

1,581 views
1 citation

Review

Published on 03 Oct 2023

MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis

in Molecular and Cellular Oncology

Aryan Rezaee
Sara Ahmadpour
Ameneh Jafari
Sarehnaz Aghili
Seyed Saeed Tamehri Zadeh
Ali Rajabi
Arash Raisi
Michael R. Hamblin
Maryam Mahjoubin-Tehran
Marzieh Derakhshan

Frontiers in Oncology

doi 10.3389/fonc.2023.1215194

3,985 views
4 citations

Review

Published on 02 Oct 2023

Pathogenesis and therapeutic implications of EBV-associated epithelial cancers

in Molecular and Cellular Oncology

Yi Hua Low
Celestine Jia Ling Loh
Daniel Yang Yao Peh
Axel Jun Ming Chu
Shuting Han
Han Chong Toh

Frontiers in Oncology

doi 10.3389/fonc.2023.1202117

6,681 views
17 citations

Original Research

Published on 29 Sep 2023

miR-186-ANXA9 signaling inhibits tumorigenesis in breast cancer

in Molecular and Cellular Oncology

Zhongrui Wang
Xiqian Zhou
Xiaochong Deng
Danrong Ye
Diya Liu
Baian Zhou
Wenfang Zheng
Xuehui Wang
Yuying Wang
Oyungerel Borkhuu

Frontiers in Oncology

doi 10.3389/fonc.2023.1166666

2,765 views
6 citations

Original Research

Published on 28 Sep 2023

Mathematical analysis identifies the optimal treatment strategy for epidermal growth factor receptor-mutated non-small cell lung cancer

in Molecular and Cellular Oncology

Qian Yu
Susumu S. Kobayashi
Hiroshi Haeno

Frontiers in Oncology

doi 10.3389/fonc.2023.1137966

3,259 views

Editorial

Published on 28 Sep 2023

Editorial: Preclinical models and emerging technologies to study the effects of the tumor microenvironment on cancer heterogeneity and drug resistance

in Molecular and Cellular Oncology

Giulia Adriani
Paola Cappello
Sara Lovisa

Frontiers in Oncology

doi 10.3389/fonc.2023.1289756

2,183 views

Perspective

Published on 26 Sep 2023

Over-expression by degradation rescue of RTKs via cancer-secreted autocrine growth factors: a Phospho-degron-driven actionable layer of post-translational regulation?

in Molecular and Cellular Oncology

Pierluigi Scalia
Stephen J. Williams

Frontiers in Oncology

doi 10.3389/fonc.2023.1278402

1,939 views
1 citation

Review

Published on 26 Sep 2023

CD98 heavy chain as a prognostic biomarker and target for cancer treatment

in Molecular and Cellular Oncology

Pu Xia
Anna Dubrovska

Frontiers in Oncology

doi 10.3389/fonc.2023.1251100

14,364 views
22 citations

Review

Published on 26 Sep 2023

Monitoring of single extracellular vesicle heterogeneity in cancer progression and therapy

in Molecular and Cellular Oncology

Yoon-Jin Lee
Shinwon Chae
Dongsic Choi

Frontiers in Oncology

doi 10.3389/fonc.2023.1256585

5,594 views
18 citations

Review

Published on 22 Sep 2023

Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers

in Molecular and Cellular Oncology

Li Lin
Qing Wu
Feifei Lu
Jiaming Lei
Yanhong Zhou
Yifei Liu
Ni Zhu
You Yu
Zhifeng Ning
Tonghui She

Frontiers in Oncology

doi 10.3389/fonc.2023.1184079

21,871 views
76 citations